Study of alpha-lipoic acid penetration in the human aqueous after topical administration

被引:17
作者
Cagini, Carlo [1 ]
Leontiadis, Arianna [1 ]
Ricci, Maria A. [1 ]
Bartolini, Anna [1 ]
Dragoni, Annalisa [1 ]
Pellegrino, Roberto M. [2 ]
机构
[1] Univ Perugia, Dept Ophthalmol, I-06100 Perugia, Italy
[2] Univ Perugia, Dept Chem, I-06100 Perugia, Italy
关键词
alpha-lipoic acid; aqueous; corneal penetration; MACULAR DEGENERATION; OXIDATIVE DAMAGE; PROTECTION; ANTIOXIDANTS; DISEASE; CELLS; DELAY; RPE;
D O I
10.1111/j.1442-9071.2010.02319.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
P>Purpose: To determine the concentration of alpha-lipoic acid in the aqueous and investigate if its topical instillation can increase quantities. Methods: A total of 70 patients selected to undergo cataract surgery were randomly divided into two groups. Group 1 was used as a control group; for the patients in Group 2, a single instillation of alpha-lipoic acid eye drops (1%) was administered. Immediately before surgery, an aliquot of 40-120 mu L of aqueous was aspirated. The individual aspirations were combined to constitute pools representing time intervals with respect to administration. The levels of alpha-lipoic acid in the aqueous were measured using gas chromatography/mass spectrometry. Results: Pool 0 was created by combining the samples of aqueous obtained from the patients in Group 1, the control group; and the level of alpha-lipoic acid was 27.5 + 2.6 ng/mL. In the other pools, the time interval between the administration of the eye drops and sampling was, respectively, 23 min, 53 min, 72 min, 93 min and 114 min; and the level of alpha-lipoic acid was 33.0 + 10.8 ng/mL, 52.0 + 2.5 ng/mL, 86.7 + 2.5 ng/mL, 91.2 + 2.5 ng/mL and 80.3 + 2.5 ng/mL. Conclusion: Our study demonstrates the presence of alpha-lipoic acid in the aqueous and indicates that its concentration increases after it is administered in the form of eye drops, reaching maximum values after around 93 min. The concentrations that are achieved in the anterior chamber allow us to theorize the possibility of exploiting the antioxidant properties of alpha-lipoic acid.
引用
收藏
页码:572 / 576
页数:5
相关论文
共 17 条
[1]   A practical assay of lipoate in biologic fluids and liver in health and disease [J].
Baker, H ;
Deangelis, B ;
Baker, ER ;
Hutner, SH .
FREE RADICAL BIOLOGY AND MEDICINE, 1998, 25 (4-5) :473-479
[2]   The role of oxidative stress in the pathogenesis of age-related macular degeneration [J].
Beatty, S ;
Koh, HH ;
Henson, D ;
Boulton, M .
SURVEY OF OPHTHALMOLOGY, 2000, 45 (02) :115-134
[3]   The pharmacology of the antioxidant lipoic acid [J].
Biewenga, GP ;
Haenen, GRMM ;
Bast, A .
GENERAL PHARMACOLOGY, 1997, 29 (03) :315-331
[4]   Oxidative damage and protection of the RPE [J].
Cai, JY ;
Nelson, KC ;
Wu, M ;
Sternberg, P ;
Jones, DP .
PROGRESS IN RETINAL AND EYE RESEARCH, 2000, 19 (02) :205-221
[5]   Effects of hypoxia on retinal pigmented epithelium cells:: Protection by antioxidants [J].
Castillo, M ;
Bellot, JL ;
García-Cabanes, C ;
Miquel, J ;
Orts, A ;
Palmero, M .
OPHTHALMIC RESEARCH, 2002, 34 (06) :338-342
[6]   A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss - AREDS Report No. 8 [J].
Kassoff, A ;
Kassoff, J ;
Buehler, J ;
Eglow, M ;
Kaufman, F ;
Mehu, M ;
Kieval, S ;
Mairs, M ;
Graig, B ;
Quattrocchi, A ;
Jones, D ;
Locatelli, J ;
Ruby, A ;
Capone, A ;
Garretson, B ;
Hassan, T ;
Trese, MT ;
Williams, GA ;
Regan, V ;
Manatrey, P ;
Streasick, P ;
Szydlowski, L ;
McIver, F ;
Bridges, C ;
Stanley, C ;
Cumming, K ;
Lewis, B ;
Zajechowski, M ;
Margherio, RR ;
Cox, MS ;
Camille, J ;
Falk, R ;
Siedlak, P ;
Neubert, C ;
Klein, ML ;
Stout, JT ;
O'Malley, A ;
Lauer, AK ;
Robertson, JE ;
Wilson, DJ ;
Beardsley, C ;
Anderson, H ;
Wallace, P ;
Smith, G ;
Howard, S ;
Dreyer, RF ;
Ma, C ;
Chenoweth, RG ;
Zilis, JD ;
Johnson, M .
ARCHIVES OF OPHTHALMOLOGY, 2001, 119 (10) :1417-1436
[7]   Abnormalities of retinal metabolism in diabetes or experimental galactosemia .3. Effects of antioxidants [J].
Kowluru, RA ;
Kern, TS ;
Engerman, RL ;
Armstrong, D .
DIABETES, 1996, 45 (09) :1233-1237
[8]   Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease [J].
Liu, JK ;
Ames, BN .
NUTRITIONAL NEUROSCIENCE, 2005, 8 (02) :67-89
[9]   Molecular aspects of lipoic acid in the prevention of diabetes complications [J].
Packer, L ;
Kraemer, K ;
Rimbach, G .
NUTRITION, 2001, 17 (10) :888-895
[10]  
Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844